<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00453752</url>
  </required_header>
  <id_info>
    <org_study_id>KB/66/2006</org_study_id>
    <nct_id>NCT00453752</nct_id>
  </id_info>
  <brief_title>Non-Invasive Diagnostic and Functional Evaluation of Cardiac Involvement in Patients With Systemic Sclerosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Warsaw</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Warsaw</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study was to assess serum N-terminal proBNP (NT-proBNP) in systemic sclerosis
      patients and to establish whether it reflects the severity of RV overload.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Elevated serum brain natriuretic peptide (BNP) levels released from myocytes of ventricles
      upon stretch have been found in patients with isolated right ventricular (RV) pressure
      overload. However, limited data suggest that serum BNP may be elevated in patients with
      systemic sclerosis (SSc), especially with RV dysfunction. The aim of this study was to assess
      serum N-terminal proBNP (NT-proBNP) in SSc patients and to establish whether it reflects the
      severity of RV overload.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2006</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Longitudinal, Prospective</time_perspective>
  </study_design_info>
  <enrollment>100</enrollment>
  <condition>Systemic Sclerosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of systemic sclerosis

        Exclusion Criteria:

          -  Cardiovascular disorders other than pulmonary hypertension

          -  Significant pulmonary function abnormalities

          -  Impaired renal function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michał Ciurzyński, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Warsaw</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ciurzyński Michał, M.D, Ph.D</last_name>
    <phone>+48 22 502 11 44</phone>
    <email>mciurzyn@amwaw.edu.pl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Piotr Pruszczyk, M.D, Ph.D.</last_name>
    <phone>+48 22 501 11 44</phone>
    <email>ppruszczyk@amwaw.edu.pl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Michał Ciurzyński</name>
      <address>
        <city>Warsaw</city>
        <state>Lindleya 4</state>
        <zip>02-005</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michał Ciurzyński, M.D, Ph.D</last_name>
      <phone>+48 22 502 11 44</phone>
      <email>mciurzyn@amwaw.edu.pl</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>March 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 28, 2007</study_first_submitted>
  <study_first_submitted_qc>March 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2007</study_first_posted>
  <last_update_submitted>March 28, 2007</last_update_submitted>
  <last_update_submitted_qc>March 28, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 29, 2007</last_update_posted>
  <keyword>systemic sclerosis</keyword>
  <keyword>pulmonary hypertension</keyword>
  <keyword>echocardiography</keyword>
  <keyword>N-Terminal proBNP</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

